Codes / ICD10CM / B74

B74 Filariasis

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Filariasis

Summary

Filariasis is a parasitic infection caused by thread-like nematodes (roundworms) of the family Filariidae. The condition is transmitted through the bite of infected mosquitoes and can lead to a range of clinical manifestations, including lymphatic damage, subcutaneous swelling, and ocular involvement. The disease is endemic in tropical and subtropical regions and may present with acute or chronic symptoms depending on the specific filarial species and host response.

Causes

Filariasis is caused by infection with filarial nematodes, primarily Wuchereria bancrofti, Brugia malayi, or Brugia timori (lymphatic filariasis) and Loa loa, Mansonella streptocerca, or Onchocerca volvulus (subcutaneous/ocular filariasis). Transmission occurs when an infected mosquito bites a human, introducing larval parasites into the bloodstream. The larvae mature into adult worms, which reside in lymphatic vessels or subcutaneous tissues, producing microfilariae that circulate in the blood and are ingested by subsequent mosquito vectors.

Risk Factors

  • Residence in or travel to endemic tropical/subtropical regions where filarial vectors are prevalent.
  • Prolonged exposure to mosquito bites, particularly in areas with poor vector control.
  • Lack of access to preventive measures such as insect repellent or bed nets.
  • Immunocompromised states, which may exacerbate disease severity.
  • Repeated exposure to infected mosquitoes, increasing the likelihood of chronic infection.

Symptoms

  • Lymphatic filariasis: Painless lymphadenopathy, limb or genital swelling (lymphedema), and recurrent acute inflammatory episodes (adenolymphangitis).
  • Subcutaneous filariasis: Calabar swellings (transient subcutaneous edema), pruritus, or migratory subcutaneous nodules.
  • Ocular filariasis: Eye pain, visual impairment, or corneal opacity (e.g., in onchocerciasis).
  • Systemic symptoms: Fever, malaise, or eosinophilia in acute infections.

Diagnosis

Diagnosis is based on clinical presentation, exposure history, and laboratory confirmation. Microscopic examination of blood (for microfilariae, often requiring nocturnal sampling for W. bancrofti) or skin snips (for O. volvulus) may identify parasites. Serologic tests (e.g., antigen detection) or molecular assays (PCR) can support diagnosis, especially in low-parasitemia cases. Imaging (e.g., ultrasound) may reveal adult worms in lymphatic vessels. Differentiation from other causes of lymphedema or eosinophilia is essential.

Treatment Options

Treatment depends on the filarial species and clinical stage. Antifilarial medications (e.g., diethylcarbamazine, ivermectin, albendazole) are used to target microfilariae and adult worms. For lymphatic filariasis, combination therapy (e.g., ivermectin + albendazole) is recommended for mass drug administration in endemic areas. Adjunctive measures include hygiene practices for lymphedema, antibiotics for secondary infections, and surgical intervention for severe complications (e.g., hydrocele repair). Management of ocular filariasis requires specialized care to preserve vision.

Prognosis and Follow-Up

Prognosis varies by species and disease stage. Early treatment of acute infections can prevent progression to chronic lymphatic damage. Chronic lymphedema may be irreversible but can be managed with supportive care. Regular follow-up is important to monitor for recurrence, complications (e.g., elephantiasis), or treatment adverse effects (e.g., Mazzotti reactions with ivermectin). In endemic regions, long-term surveillance and preventive measures (e.g., vector control) are critical to reduce transmission.

Complications

  • Chronic lymphedema leading to elephantiasis (skin thickening, tissue fibrosis).
  • Hydrocele (scrotal swelling) or genital deformities.
  • Secondary bacterial infections of swollen tissues.
  • Visual impairment or blindness (in onchocerciasis).
  • Eosinophilic meningitis or encephalitis (rare, with Angiostrongylus cantonensis co-infection).

Lifestyle & Prevention

  • Use insect repellent and bed nets to avoid mosquito bites in endemic areas.
  • Wear protective clothing (long sleeves, pants) during peak biting hours.
  • Practice good hygiene to reduce skin infections in lymphedematous limbs.
  • Participate in community-based mass drug administration programs in endemic regions.
  • Seek pre-travel medical advice for prophylaxis if visiting high-risk areas.

When to Seek Professional Help

  • Persistent swelling of limbs, genitals, or extremities.
  • Unexplained skin rashes, nodules, or eye pain.
  • Systemic symptoms (fever, chills) after travel to endemic regions.
  • Worsening lymphedema or signs of infection (redness, warmth, pus).
  • Sudden visual changes or eye discomfort.

Tips for Medical Coders

  • Code B74 is used for filariasis, including lymphatic, subcutaneous, and ocular forms, without specifying the causative species.
  • Document the anatomical site (e.g., lymphatic, subcutaneous, ocular) and clinical manifestations (e.g., lymphedema, elephantiasis) to support coding accuracy.
  • Differentiate filariasis from other parasitic infections (e.g., onchocerciasis) using clinical and laboratory findings.
  • Ensure coding aligns with the specific filarial type if documented, as some subtypes (e.g., on
Book a walkthrough

B74 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.